JHS Svendgaard Laboratories Limited has informed the Exchange about approval of JHS Svendgaard Laboratories Employee Stock Options Scheme-2025
JHS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of JHS Svendgaard Laboratories approved an Employee Stock Option Scheme (ESOP-2025) on August 21, 2025. The scheme creates a pool of 40 lakh options, each convertible into one equity share of Rs. 10 face value, to be issued via fresh allotment (direct route). No grants have been made under the scheme yet, and the exercise price will be linked to the market price at the time of grant, with possible discount but not below face value. Vesting will start after 1 year and can extend up to 5 years from the grant date, with vested options exercisable within 5 years of vesting. The scheme is in compliance with SEBI (SBEB & SE) Regulations, 2021 and will be administered by the Nomination and Remuneration Committee.
This is a potential dilution event as up to 40 lakh new shares (roughly the scale of a fresh equity issuance) could be allotted to employees over time. Since no grants have been made yet, the immediate impact on shareholders is limited, but the scheme could lead to equity dilution if fully utilized.